Zdrowie i gospodarka · 18/08/2010
FDA Clears DIASTAT Rectal Gel for Approval
The FDA has determined that DIASTAT (diazepam rectal gel) in various concentrations was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications for the medication.
Source: Federal Register — Health and Human ServicesOpen original release →